• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类嗜T淋巴细胞病毒1型葡萄膜炎继发性青光眼的发病机制

Mechanism of Secondary Glaucoma Development in HTLV-1 Uveitis.

作者信息

Zong Yuan, Kamoi Koju, Ando Naoko, Kurozumi-Karube Hisako, Ohno-Matsui Kyoko

机构信息

Department of Ophthalmology and Visual Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

出版信息

Front Microbiol. 2022 Jun 2;13:738742. doi: 10.3389/fmicb.2022.738742. eCollection 2022.

DOI:10.3389/fmicb.2022.738742
PMID:35722286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9201414/
Abstract

Human T-cell lymphotropic virus type 1 (HTLV-1) was the first retrovirus identified as the causative agent of human diseases, such as adult T-cell leukemia, HTLV-1-associated myelopathy, and HTLV-1 uveitis (HU). HU is one of the most frequent ocular inflammatory diseases in endemic areas, which has raised considerable public health concerns. Approximately 30% of HU patients develop secondary glaucoma, which is higher than the general uveitis incidence. We therefore investigated the mechanism underlying the high incidence of glaucoma secondary to HU After contact with HTLV-1-producing T cells (MT-2), human trabecular meshwork cells (HTMCs) were infected. The infected cells increased in number, and nuclear factor (NF)-κB expression was activated. Contact between MT-2 cells and HTMCs resulted in significantly upregulated production of inflammatory cytokines, such as IL-6, and chemokines, such as CXCL10, CCL2, and CXCL-8. These findings indicate that the mechanism underlying secondary glaucoma in HU may involve proliferation of trabecular meshwork tissue after contact with HTLV-1-infected cells, resulting in decreased aqueous humor outflow. Upregulated production of inflammatory cytokines and chemokines simultaneously disrupts the normal trabecular meshwork function. This mechanism presumably leads to increased intraocular pressure, eventually resulting in secondary glaucoma.

摘要

人类嗜T细胞病毒1型(HTLV-1)是首个被鉴定为人类疾病病原体的逆转录病毒,这些疾病包括成人T细胞白血病、HTLV-1相关脊髓病以及HTLV-1葡萄膜炎(HU)。HU是流行地区最常见的眼部炎性疾病之一,这引发了相当大的公共卫生关注。大约30%的HU患者会继发青光眼,这一比例高于一般葡萄膜炎的发病率。因此,我们研究了HU继发青光眼高发的潜在机制。在与产生HTLV-1的T细胞(MT-2)接触后,人小梁网细胞(HTMCs)被感染。被感染的细胞数量增加,核因子(NF)-κB表达被激活。MT-2细胞与HTMCs之间的接触导致炎性细胞因子如IL-6以及趋化因子如CXCL10、CCL2和CXCL-8的产生显著上调。这些发现表明,HU继发青光眼的潜在机制可能涉及与HTLV-1感染细胞接触后小梁网组织的增殖,从而导致房水流出减少。炎性细胞因子和趋化因子产生的上调同时破坏了正常的小梁网功能。这种机制大概会导致眼压升高,最终引发继发青光眼。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6499/9201414/32dd8e33161e/fmicb-13-738742-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6499/9201414/a7962e7e97ea/fmicb-13-738742-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6499/9201414/63ca048a4904/fmicb-13-738742-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6499/9201414/d864c289d319/fmicb-13-738742-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6499/9201414/e5b2ba9aadd5/fmicb-13-738742-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6499/9201414/3c6950f69cb6/fmicb-13-738742-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6499/9201414/32dd8e33161e/fmicb-13-738742-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6499/9201414/a7962e7e97ea/fmicb-13-738742-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6499/9201414/63ca048a4904/fmicb-13-738742-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6499/9201414/d864c289d319/fmicb-13-738742-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6499/9201414/e5b2ba9aadd5/fmicb-13-738742-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6499/9201414/3c6950f69cb6/fmicb-13-738742-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6499/9201414/32dd8e33161e/fmicb-13-738742-g006.jpg

相似文献

1
Mechanism of Secondary Glaucoma Development in HTLV-1 Uveitis.人类嗜T淋巴细胞病毒1型葡萄膜炎继发性青光眼的发病机制
Front Microbiol. 2022 Jun 2;13:738742. doi: 10.3389/fmicb.2022.738742. eCollection 2022.
2
Ripasudil as a Potential Therapeutic Agent in Treating Secondary Glaucoma in HTLV-1-Uveitis: An In Vitro Analysis.利帕舒地尔在治疗 HTLV-1 葡萄膜炎继发青光眼中的潜在治疗作用:体外分析。
Int J Mol Sci. 2024 Mar 12;25(6):3229. doi: 10.3390/ijms25063229.
3
HTLV-1 uveitis.人类嗜T淋巴细胞病毒1型葡萄膜炎
Front Microbiol. 2012 Jul 24;3:270. doi: 10.3389/fmicb.2012.00270. eCollection 2012.
4
Immunologic and virologic characterization of the primary infiltrating cells in the aqueous humor of human T-cell leukemia virus type-1 uveitis. Accumulation of the human T-cell leukemia virus type-1-infected cells and constitutive expression of viral and interleukin-6 messenger ribonucleic acids.人类T细胞白血病病毒1型葡萄膜炎房水中原发性浸润细胞的免疫和病毒学特征。人类T细胞白血病病毒1型感染细胞的积聚以及病毒和白细胞介素-6信使核糖核酸的组成性表达。
Invest Ophthalmol Vis Sci. 1997 Mar;38(3):676-89.
5
Safety of intraocular anti-VEGF antibody treatment under HTLV-1 infection.在 HTLV-1 感染下的眼内抗 VEGF 抗体治疗的安全性。
Front Immunol. 2023 Jan 25;13:1089286. doi: 10.3389/fimmu.2022.1089286. eCollection 2022.
6
[Intraocular inflammation and homeostasis of the eye].[眼内炎症与眼的内环境稳定]
Nippon Ganka Gakkai Zasshi. 2009 Mar;113(3):344-77; discussion 378.
7
Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-I) uveitis. Detection of HTLV-I-infected T cells in the eye and their constitutive cytokine production.人类嗜T淋巴细胞病毒1型(HTLV-I)葡萄膜炎的免疫病理机制。眼部HTLV-I感染T细胞的检测及其组成性细胞因子产生。
J Clin Invest. 1995 Feb;95(2):852-8. doi: 10.1172/JCI117735.
8
Updates on HTLV-1 Uveitis.HTLV-1 葡萄膜炎最新进展。
Viruses. 2022 Apr 12;14(4):794. doi: 10.3390/v14040794.
9
Safety of Infliximab for the Eye Under Human T-Cell Leukemia Virus Type 1 Infectious Conditions .英夫利昔单抗在人类1型T细胞白血病病毒感染情况下用于眼部的安全性
Front Microbiol. 2019 Sep 18;10:2148. doi: 10.3389/fmicb.2019.02148. eCollection 2019.
10
Human T lymphotropic virus type 1 uveitis.1型人类嗜T淋巴细胞病毒葡萄膜炎
Br J Ophthalmol. 1994 Feb;78(2):149-54. doi: 10.1136/bjo.78.2.149.

引用本文的文献

1
From tumor microenvironment to ocular hypertension: unraveling the pathogenesis and therapeutic strategies of cancer-related glaucoma.从肿瘤微环境到高眼压症:解析癌症相关性青光眼的发病机制与治疗策略
Front Med (Lausanne). 2025 Aug 14;12:1628325. doi: 10.3389/fmed.2025.1628325. eCollection 2025.
2
Human T-Lymphotropic Virus (HTLV): Epidemiology, Genetic, Pathogenesis, and Future Challenges.人类嗜T淋巴细胞病毒(HTLV):流行病学、遗传学、发病机制及未来挑战
Viruses. 2025 May 1;17(5):664. doi: 10.3390/v17050664.
3
Ocular Toxoplasmosis: Advances in Biology, Clinical Manifestations, Diagnostics, and Therapy.

本文引用的文献

1
Updates on HTLV-1 Uveitis.HTLV-1 葡萄膜炎最新进展。
Viruses. 2022 Apr 12;14(4):794. doi: 10.3390/v14040794.
2
HTLV-1 uveitis and Graves' disease presenting with sudden onset of blurred vision.成人T细胞白血病病毒1型葡萄膜炎和格雷夫斯病伴视力突然模糊。
Lancet. 2022 Jan 1;399(10319):60. doi: 10.1016/S0140-6736(21)02442-9.
3
Association of Genetic Polymorphisms in Oxidative Stress and Inflammation Pathways with Glaucoma Risk and Phenotype.氧化应激和炎症途径中的基因多态性与青光眼风险及表型的关联
眼部弓形虫病:生物学、临床表现、诊断与治疗的进展
Pathogens. 2024 Oct 14;13(10):898. doi: 10.3390/pathogens13100898.
4
Ophthalmic Use of Targeted Biologics in the Management of Intraocular Diseases: Current and Emerging Therapies.靶向生物制剂在眼科疾病治疗中的应用:当前及新兴疗法
Antibodies (Basel). 2024 Oct 11;13(4):86. doi: 10.3390/antib13040086.
5
Applications of Biological Therapy for Latent Infections: Benefits and Risks.生物疗法在潜伏感染中的应用:益处与风险。
Int J Mol Sci. 2024 Aug 24;25(17):9184. doi: 10.3390/ijms25179184.
6
Ripasudil as a Potential Therapeutic Agent in Treating Secondary Glaucoma in HTLV-1-Uveitis: An In Vitro Analysis.利帕舒地尔在治疗 HTLV-1 葡萄膜炎继发青光眼中的潜在治疗作用:体外分析。
Int J Mol Sci. 2024 Mar 12;25(6):3229. doi: 10.3390/ijms25063229.
7
Safety of intraocular anti-VEGF antibody treatment under HTLV-1 infection.在 HTLV-1 感染下的眼内抗 VEGF 抗体治疗的安全性。
Front Immunol. 2023 Jan 25;13:1089286. doi: 10.3389/fimmu.2022.1089286. eCollection 2022.
J Clin Med. 2021 Mar 9;10(5):1148. doi: 10.3390/jcm10051148.
4
Horizontal transmission of HTLV-1 causing uveitis.导致葡萄膜炎的人类嗜T淋巴细胞病毒1型(HTLV-1)的水平传播。
Lancet Infect Dis. 2021 Apr;21(4):578. doi: 10.1016/S1473-3099(21)00063-3.
5
Evaluation of the Safety of Adalimumab for the Eye Under HTLV-1 Infection Status: A Preliminary Study.评估阿达木单抗在人类嗜T淋巴细胞病毒1型(HTLV-1)感染状态下对眼部的安全性:一项初步研究。
Front Microbiol. 2020 Dec 23;11:522579. doi: 10.3389/fmicb.2020.522579. eCollection 2020.
6
HOX genes and the NF-κB pathway: A convergence of developmental biology, inflammation and cancer biology.HOX 基因与 NF-κB 通路:发育生物学、炎症和癌症生物学的交汇点。
Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188450. doi: 10.1016/j.bbcan.2020.188450. Epub 2020 Oct 10.
7
An update on human T-cell leukemia virus type I (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) focusing on clinical and laboratory biomarkers.关于I型人类T细胞白血病病毒(HTLV-1)相关脊髓病/热带痉挛性截瘫(HAM/TSP)的最新进展,重点关注临床和实验室生物标志物。
Pharmacol Ther. 2021 Feb;218:107669. doi: 10.1016/j.pharmthera.2020.107669. Epub 2020 Aug 21.
8
Inflammation and tissue homeostasis: the NF-κB system in physiology and malignant progression.炎症和组织稳态:NF-κB 系统在生理和恶性进展中的作用。
Mol Biol Rep. 2020 May;47(5):4047-4063. doi: 10.1007/s11033-020-05410-w. Epub 2020 Apr 1.
9
HTLV-1 in Ophthalmology.眼科中的人类嗜T淋巴细胞病毒1型
Front Microbiol. 2020 Mar 11;11:388. doi: 10.3389/fmicb.2020.00388. eCollection 2020.
10
Tackling HTLV-1 infection in ophthalmology: a nationwide survey of ophthalmic care in an endemic country, Japan.攻克眼科中的 HTLV-1 感染:在日本这一流行国家,对眼科护理的全国性调查。
Br J Ophthalmol. 2020 Dec;104(12):1647-1651. doi: 10.1136/bjophthalmol-2019-315675. Epub 2020 Mar 9.